WebKnight Application Firewall Alert
VHEST is the largest Hypertension PMS study on Valsartan in Syria that will include 1500 patients and more than 100 medical physician from Syria.
VHEST, Valsartan, Hypertension, Syria, Syrian Study, PMS, Monotherapy, Combination Therapy, ARB, Angiotensin Receptor Blocker
Is this your site? Certify your site and update informations
